Explainable AI unravels sepsis heterogeneity via coagulation-inflammation profiles for prognosis and stratification

L Li Zhu Z Zengtian Chen H Hong Zhang H Hongjun Chen (Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine) L Lanqi Liu W Wei Yu K Kai Wu (BNLMS, College of Chemistry and Molecular Engineering) Y Yijin Chen (Zhejiang Key Laboratory of Excited-State Energy Conversion and Energy Storage, Department of Chemistry) X Xingyu Tao Z Zefeng Yu L Linhui Shi J Jialian Wang F Fan Zhang J Jiaying Shen F Fen Liu (State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences) C Chongke Hu Y Yangguang Ren T Tzu-Ming Liu Y Yang Luo F Fei Guo B Bailin Niu

Abstract

Abstract Sepsis is a leading cause of hospital mortality, and its significant heterogeneity complicates prognosis and stratification. To address this challenge, we developed an explainable artificial intelligence prognostic model (SepsisFormer, a transformer-based neural network) and an automated risk-stratification tool (SMART) for sepsis. In a multi-center retrospective study of 12,408 sepsis patients, SepsisFormer achieved high predictive accuracy (AUC: 0.9301, sensitivity: 0.9346, and specificity: 0.8312). SMART (AUC: 0.7360) surpassed most established scoring systems. Seven coagulation-inflammatory routine laboratory measurements and patient age were identified to classify patients’ four risk levels (mild, moderate, severe, dangerous) and two subphenotypes (CIS1 and CIS2), each with distinct clinical characteristics and mortality rates. Notably, patients with moderate/severe levels or CIS2 derive more significant benefits from anticoagulant treatment. Our work, therefore, offers a set of simple, real-time executable tools for sepsis heterogeneity, demonstrating the potential to enhance sepsis clinical practice globally, particularly in resource-constrained healthcare settings.

Article Details

Volume / Issue Vol. 16, Issue 1
Published November 24, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (21)

L

Li Zhu

Z

Zengtian Chen

H

Hong Zhang

H

Hongjun Chen

Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine

L

Lanqi Liu

W

Wei Yu

K

Kai Wu

BNLMS, College of Chemistry and Molecular Engineering

Y

Yijin Chen

Zhejiang Key Laboratory of Excited-State Energy Conversion and Energy Storage, Department of Chemistry

X

Xingyu Tao

Z

Zefeng Yu

L

Linhui Shi

J

Jialian Wang

F

Fan Zhang

J

Jiaying Shen

F

Fen Liu

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences

C

Chongke Hu

Y

Yangguang Ren

T

Tzu-Ming Liu

Y

Yang Luo

F

Fei Guo

B

Bailin Niu